PUREGON 300 IU/0.36ml Price

Overview

Welcome to Dwaey, specifically on PUREGON 300 IU/0.36ml page.
This medicine contains an important and useful components, as it consists of
Follitropin betais available in the market in concentration

Name

Follitropin Beta

Precaution

May result in multiple births. Ovarian hyperstimulation syndrome (OHSS), serious pulmonary conditions and thromboembolic events may occur. Evaluate patients for hypothyroidism, adrenocortical deficiency, hyperprolactinaemia, pituitary and hypothalamic tumors before starting therapy.

Indication

Ovulation induction, Assisted reproductive technologies

Contra indication

Abnormal genital bleeding of undetermined origin, hormone sensitive malignancies; ovary, breast, uterus, hypothalamus, testes or pituitary gland tumor; ovarian cysts or enlargement not due to the polycystic ovary syndrome; high levels of FSH indicating primary gonadal failure (ovarian or testicular); uncontrolled thyroid or adrenal dysfunction; presence of any cause of infertility other than anovulation; hypersensitivity; pregnancy, lactation.

Side Effect

Ovarian cysts, mild to severe inj site reactions, headache, mild to moderate OHSS, abdominal pain, GI disturbances. Rarely, severe OHSS, ovarian torsion, thromboembolism, mild systemic allergic reactions.

Pregnancy Category ID

5

Mode of Action

Follitropin beta is a human FSH preparation of recombinant DNA origin. It stimulates ovarian follicular growth in women who do not have primary ovarian failure.

Interaction

Concomitant use w/ clomiphene citrate may enhance the follicular response. A higher dose may be needed after pituitary desensitisation induced by a GnRH agonist.

Pregnancy Category Note

Information not available

Adult Dose

Child Dose

Renal Dose

Administration